Home › Brain Tumors › Ohio › Dayton
Brain Tumors clinical trials in Dayton, OH
4 studies for Brain Tumors are looking for participants at sites in and around Dayton (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
RecruitingPhase 2
- Dayton Physician LLC-Miami Valley Hospital North, Dayton
- Greater Dayton Cancer Center, Kettering · 5 mi away
- Kettering Medical Center, Kettering · 5 mi away
- and 6 more
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
RecruitingPhase 1/2
- Miami Valley Hospital South, Centerville · 9 mi away
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
RecruitingObservational study
- Kettering Health, Kettering · 5 mi away
REMASTer: REcurrent Brain Metastases After SRS Trial
Recruiting
- Kettering Health, Kettering · 5 mi away
About Brain Tumors
A brain tumor is a growth of abnormal cells in the brain tissue. Learn the types of tumors, symptoms, how they are diagnosed and treatment options.
More about Brain Tumors on MedlinePlus
Brain Tumors trials in other cities
- Houston, TX35 studies
- Boston, MA28 studies
- New York City, NY25 studies
- Washington, DC20 studies
- Los Angeles, CA16 studies
- Miami, FL15 studies
- Durham, NC14 studies
- St. Louis, MO12 studies
- Rochester, MN12 studies
- Columbus, OH11 studies
- Baltimore, MD11 studies
- Chicago, IL11 studies
Other studies in Dayton
- Lung Cancer14 studies
- Non-Small Cell Lung Cancer13 studies
- Ovarian Cancer9 studies
- Endometrial Cancer8 studies
- Heart Failure8 studies
- Cancer (all types)8 studies
- Steatotic Liver Disease8 studies
- Breast Cancer7 studies
- Obesity7 studies
- Melanoma7 studies
- Prostate Cancer7 studies
- Ulcerative Colitis7 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.